Loading
Latest filing published 26 Jun 2018 for MedReleaf Corp., €177k.
No signal scores available.
Ivan Latysh appears in our data through filings on MedReleaf Corp. shares, published by SEDI. We count 3 filings, every one of them for a trade on 25 June 2018.
No open-market purchase appears, only 2 sales worth €944k. The rest of the record consists of 1 option exercise.
Most recently, on 26 June 2018, the filings show an option exercise worth €177k in MedReleaf Corp. The median gap between a trade and its publication by SEDI is 1 day. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations